Nuveen
ORKA

Nuveen’s Oruka Therapeutics ORKA Stock Holding History

Nuveen’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.7M Buy
249,267
+162,329
+187% +$10.8M 0.01% 1155
2026
Q1 		$4.26M Buy
86,938
+591
+0.7% +$20.5K ﹤0.01% 1952
2025
Q4 		$2.62M Buy
86,347
+51,034
+145% +$1.42M ﹤0.01% 2177
2025
Q3 		$679K Hold
35,313
– – ﹤0.01% 2784
2025
Q2 		$396K Buy
+35,313
New +$368K ﹤0.01% 2953

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Nuveen's ORKA Position: Q2 2026 in Review

Nuveen increased its Oruka Therapeutics (ORKA) stake by 187% in Q2 2026, buying an estimated $10.8M and bringing the position to 249,267 shares worth $23.7M. The position accounts for 0.01% of the portfolio, ranked #1155.

Nuveen first reported a position in ORKA in Q2 2025 and has held it in 5 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Nuveen held 249,267 shares of Oruka Therapeutics worth $23.7M as of Q2 2026.
  • Nuveen bought 162,329 Oruka Therapeutics shares in Q2 2026, an estimated $10.8M.
  • Oruka Therapeutics made up 0.01% of Nuveen's portfolio in Q2 2026, its #1155 holding.
  • Nuveen first reported a position in Oruka Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.